GlassScriptPhysician profile
Neil M Skemp
NPI 1477504876
$4,913.52
in general payments reported to CMS, 2019-2025
37 companies · $665 in 2025
The $665 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196 · 2020: $463 · 2021: $772 · 2022: $934 · 2023: $1,165 · 2024: $719 · 2025: $665.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,549.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $746.87 | 2019-2025 | Speedicath, Porges Coloplast, Altis |
| Axonics, INC. | $443.99 | 2021-2024 | Axonics |
| Medtronic, INC. | $405.48 | 2022-2024 | Interstim |
| Olympus America INC. | $346.98 | 2021-2025 | Itind System |
| Teleflex LLC | $327.15 | 2021-2023 | Urolift |
| Srs Medical Systems, INC. | $292.61 | 2021-2022 | |
| Antares Pharma, INC. | $277.33 | 2019-2024 | Xyosted, Tlando, Nocdurna |
| Dendreon Pharmaceuticals LLC | $262.16 | 2019-2024 | Provenge |
| Conmed Corporation | $161.89 | 2023 | Airseal |
| Abbvie INC. | $153.86 | 2020-2025 | Botox |
| Medtronic USA, INC. | $143.94 | 2020 | |
| Convatec INC. | $130.35 | 2022-2023 | |
| Laborie Medical Technologies Corp. | $125.46 | 2025 | |
| Myovant Sciences INC. | $122.19 | 2021-2022 | |
| C. R. Bard, INC. & Subsidiaries | $121.37 | 2023-2024 | Bard Urinary Drainage Bag |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $106.55 | 2020-2025 | Keytruda |
| Astellas Pharma US INC | $103.85 | 2019-2025 | Xtandi |
| Progenics Pharmaceuticals, INC. | $98.58 | 2021-2024 | Pylarify |
| Blue Earth Diagnostics | $83.84 | 2020-2025 | Posluma |
| Immunitybio, INC. | $55.32 | 2024-2025 | |
| Verity Pharmaceuticals INC. | $47.25 | 2024-2025 | Trelstar |
| Halozyme INC | $45.23 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $32.93 | 2024-2025 | Lynparza |
| Accord Healthcare, INC. | $31.35 | 2025 | |
| Pfizer INC. | $30.41 | 2021-2022 | |
| Tempus Ai, INC | $29.07 | 2025 | Xt Cdx |
| Abc Home Medical Supply, INC. | $25.66 | 2022-2024 | |
| Dornier Medtech America, INC | $20.57 | 2019 | |
| 180 Medical, INC. | $19.49 | 2024 | |
| Angiodynamics, INC. | $18.60 | 2024 | Nanoknife |
| Ethicon US, LLC | $18.49 | 2022 | |
| Genzyme Corporation | $16.32 | 2022 | |
| Telix Pharmaceuticals | $15.58 | 2023 | Illuccix |
| Sumitomo Pharma America, INC. | $14.41 | 2025 | Orgovyx |
| Karl Storz Endoscopy-America | $13.94 | 2019 | |
| Urogen Pharma, INC. | $13.04 | 2023 | Jelmyto |
| Endo Pharmaceuticals INC. | $11.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Skemp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.